Both legacy players and startups have an important role to play when it comes to medical innovation—they need to work together to meet the increasing demand for minimally invasive treatments, value-based care and innovative, not incremental therapies. This is a mutually beneficial relationship that is key to medical technology development.
Combining imaging technology with artificial intelligence can help address both challenges in healthcare disparities as well as in patient care.
MedExecWomen board President, Helen Routh, noted at a recent conference: “Innovation in healthcare, particularly post-COVID, requires us to work across industry sectors, alongside clinicians and payers.” Laurie Halloran, president & CEO of Halloran Consultant Group shares insights she heard from a panel of strong female leaders on how the industry can take action to improve health inequities, which will be an ongoing topic at future conferences.
Building fruitful development partnerships between companies, governments and researchers will enable the most promising and impactful deployments in healthcare.
A global pandemic is still upon us, but that certainly does not mean that healthcare technology innovation is standing still. To help the medical device industry look to the future and prepare, experts from regulation and academia alike are bringing attention to the acceleration and pitfalls of innovation.
The shift towards more home-based and distance-care may further change in a post-COVID environment.
Healthcare systems around the world are under increasing pressure to treat a rapidly growing, aging population. This was worsened by the COVID-19 pandemic, which left medical professionals needing to treat more people with less time and limited resources. This article explores why medtech is uniquely placed to ease the pressures on healthcare systems by offering faster and more cost-effective care while improving patient outcomes.
The program highlights the agency’s commitment to improving safety and supporting innovation, and is a welcome counterpart to the Breakthrough Devices Program.
We have the opportunity to refine processes that were implemented in a hurry during the pandemic, along with the insight to improve the entire healthcare system.
The record-high number of authorizations last year was a significant jump over 2019.